A novel chimeric antigen receptor redirecting T-cell specificity towards CD26 + cancer cells.

MLA

Zhou, Shu, et al. “A Novel Chimeric Antigen Receptor Redirecting T-Cell Specificity towards CD26 + Cancer Cells.” Leukemia, vol. 35, no. 1, Jan. 2021, pp. 119–29. EBSCOhost, https://doi.org/10.1038/s41375-020-0824-y.

APA

Zhou, S., Li, W., Xiao, Y., Zhu, X., Zhong, Z., Li, Q., Cheng, F., Zou, P., You, Y., & Zhu, X. (2021). A novel chimeric antigen receptor redirecting T-cell specificity towards CD26 + cancer cells. Leukemia, 35(1), 119–129. https://doi.org/10.1038/s41375-020-0824-y

Chicago

Zhou, Shu, Weiming Li, Yi Xiao, Xiaoying Zhu, Zhaodong Zhong, Qing Li, Fanjun Cheng, Ping Zou, Yong You, and Xiaojian Zhu. 2021. “A Novel Chimeric Antigen Receptor Redirecting T-Cell Specificity towards CD26 + Cancer Cells.” Leukemia 35 (1): 119–29. doi:10.1038/s41375-020-0824-y.